Announce Date | 04/25/2024 |
EPS Normalized Actual | $2 (Beat by $0.17) |
EPS GAAP Actual | $2 (Beat by $0.17) |
Revenue Actual | $20.12B |
Revenue Surprise | Beat by $20120M |
Announce Date | 07/01/2024 (Pre-Market) |
EPS Normalized Estimate | $2.28048 |
EPS GAAP Estimate | $2.28048 |
Revenue Estimate | $19.634545147B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 16.79 | 10.73 | 16.38047 | 17.25551 | 7 |
Dec 2027 | 16.8525 | 10.69 | 16.44145 | 17.31974 | 6 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | 0.57 | 0.57 | 20.12B | 1.79% | 20120M |
FQ4 2021 (Dec 2021) | 0.34 | 0.34 | 20.785B | 2.14% | 20785M |
FQ3 2021 (Sep 2021) | 0.55 | 0.55 | 19.624B | 1.79% | 19624M |
FQ2 2021 (Jun 2021) | 0.78 | 0.78 | 19.95B | 11.42% | 19950M |
FQ1 2021 (Mar 2021) | 0.75 | 0.75 | 19.759B | 43.76% | 19759M |
FQ4 2020 (Dec 2020) | 0.6 | 0.6 | 20.341B | 41.61% | 20341M |
FQ3 2020 (Sep 2020) | 1.01 | 1.01 | 19.272B | 42.61% | 19272M |
FQ2 2020 (Jun 2020) | 0.09 | 0.09 | 17.671B | 37.87% | 17671M |
FQ4 Announce Date
07/01/2024 (Pre-Market)
Consensus EPS Estimates
2.28048
Consensus Revenue Estimates
19.634545147B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 3.07 | -- | 2.98806 | 3.14854 | 9 |
FQ3 2026 (Jul 2026) | 3.06 | -- | 2.97832 | 3.13828 | 9 |
FQ2 2026 (Jun 2026) | 3.48 | -- | 3.39236 | 3.58007 | 4 |
FQ1 2026 (Mar 2026) | 2.9 | -- | 2.82697 | 2.98339 | 4 |
FQ4 2025 (Oct 2025) | 2.83157 | -- | 2.75599 | 2.90401 | 6 |
FQ3 2025 (Jul 2025) | 2.76143 | -- | 2.68772 | 2.83207 | 6 |
FQ2 2025 (Jun 2025) | 2.766 | -- | 2.69634 | 2.84553 | 5 |
FQ1 2025 (Mar 2025) | 2.526 | -- | 2.46239 | 2.59863 | 5 |
FQ4 2024 (Oct 2024) | 2.41955 | -- | 2.28338 | 2.50334 | 12 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 20.51B | -- | 20.09B | 20.91B | 8 |
FQ3 2026 (Jul 2026) | 20.36B | -- | 19.94B | 20.76B | 5 |
FQ2 2026 (Jun 2026) | 23.95B | -- | 23.48B | 24.47B | 5 |
FQ1 2026 (Mar 2026) | 24.63B | -- | 24.15B | 25.17B | 5 |
FQ4 2025 (Oct 2025) | 20.3B | -- | 19.88B | 20.7B | 6 |
FQ3 2025 (Jul 2025) | 20.08B | -- | 19.67B | 20.47B | 4 |
FQ2 2025 (Jun 2025) | 20.28B | -- | 19.89B | 20.73B | 4 |
FQ1 2025 (Mar 2025) | 20.27B | -- | 19.88B | 20.72B | 4 |
FQ4 2024 (Oct 2024) | 19.88B | -- | 19.47B | 20.05B | 11 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | 0.57 | 0.57 | 100% | |
FQ4 2021 (Dec 2021) | 0.34 | 0.34 | 100% | |
FQ3 2021 (Sep 2021) | 0.55 | 0.55 | 100% | |
FQ2 2021 (Jun 2021) | 0.78 | 0.78 | 100% | |
FQ1 2021 (Mar 2021) | 0.75 | 0.75 | 100% | |
FQ4 2020 (Dec 2020) | 0.6 | 0.6 | 100% | |
FQ3 2020 (Sep 2020) | 1.01 | 1.01 | 100% | |
FQ2 2020 (Jun 2020) | 0.09 | 0.09 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $20.12B | $20120M | 100% |
FQ4 2021 (Dec 2021) | $0B | $20.79B | $20785M | 100% |
FQ3 2021 (Sep 2021) | $0B | $19.62B | $19624M | 100% |
FQ2 2021 (Jun 2021) | $0B | $19.95B | $19950M | 100% |
FQ1 2021 (Mar 2021) | $0B | $19.76B | $19759M | 100% |
FQ4 2020 (Dec 2020) | $0B | $20.34B | $20341M | 100% |
FQ3 2020 (Sep 2020) | $0B | $19.27B | $19272M | 100% |
FQ2 2020 (Jun 2020) | $0B | $17.67B | $17671M | 100% |